The BMP2 Knockout CAL-27 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal cell population derived from the CAL-27 human oral squamous cell carcinoma line, designed for loss-of-function studies of the BMP2 gene. This product provides a heterogeneous knockout pool in which BMP2 expression is disrupted via CRISPR/Cas9-mediated gene targeting, enabling robust investigation of BMP2-dependent signaling in an epithelial tumor context. The polyclonal format captures diverse editing events without clonal selection, offering a practical and biologically representative model for functional genomics, pathway dissection, and drug screening applications.
The parental CAL-27 cell line is a well-characterized model of tongue squamous cell carcinoma, widely employed in head and neck cancer research to examine tumor cell invasion, metastasis, and therapeutic responses. CAL-27 cells exhibit epithelial morphology and retain key oncogenic drivers and signaling aberrations common in oral squamous cell carcinomas, making them a relevant platform for studying the molecular mechanisms underlying disease progression. This knockout pool thus leverages an established cancer model to elucidate BMP2??s contributions to malignant phenotypes in a disease-relevant background.
BMP2 encodes a secreted ligand of the TGF-beta superfamily that regulates diverse cellular processes via canonical and non-canonical pathways. Binding to heteromeric BMPR1A/BMPR1B and BMPR2 receptor complexes induces SMAD1/5/8 phosphorylation; these activated SMADs partner with SMAD4 to enter the nucleus and direct expression of target genes such as ID1, RUNX2, and ALP. Simultaneously, MAPK/ERK and PI3K/AKT signaling modules are engaged, adding contextual versatility. BMP2 expression is modulated by upstream inputs including retinoic acid, Wnt/beta-catenin, and inflammatory cytokines (TNF-alpha, IL-1beta), while its bioavailability is restricted by antagonists like Noggin, Chordin, and Gremlin, ensuring tight spatiotemporal control of signaling intensity.
In the context of CAL-27 oral squamous cell carcinoma, BMP2 exerts pleiotropic effects on tumor cell proliferation, migration, and invasion, often exhibiting dual roles depending on the microenvironmental milieu. The knockout of BMP2 in this cell background permits dissection of its specific contributions to head and neck cancer aggressiveness, including epithelial-mesenchymal transition (EMT)-like processes and crosstalk with Wnt and MAPK pathways. Moreover, the model enables evaluation of how loss of BMP2 signaling alters responses to therapeutic agents or paracrine interactions within the tumor niche, providing a valuable tool for translational oncology research.
Researchers can employ this BMP2 knockout pool in a broad range of experimental workflows to interrogate BMP2 biology and screen for pathway modulators. Representative assays include Western blotting to quantify SMAD1/5/8 phosphorylation and downstream effector expression, RT-qPCR for transcriptional targets, Boyden chamber migration and invasion assays to assess metastatic potential, and ALP activity measurements to monitor osteogenic differentiation. Additional applications encompass co-immunoprecipitation for receptor-ligand complexes, RNA-seq transcriptome profiling, and high-content imaging of SMAD4 nuclear translocation. For further details or to discuss your specific project needs, please contact Ascent Research.
